Trucheck is a new blood-based paradigm in multicancer detection. The Intelli test can detect over 70 different types of solid tumours and only requires 25ml blood sample. The test will provide either a negative or positive result. A negative result suggests that no circulating tumour cells were detected in the given blood sample with 88.2% sensitivity rate. A positive result occurs when CTCs are detected in the given blood sample which is suggestive of malignancy with 99.9% sensitivity. This can be further analysed to determine the tissue or organ of origin. Following your blood draw results, our clinical director will provide you with a consultation and next steps.
CTCs are not detected in cancer-free individuals or those with benign (non-cancerous) conditions. CTCs permit detection of cancers with high sensitivity and enable differentiation between cancer patients and healthy individuals with high specificity.
Download the Trucheck Intelli brochure here.